BioCryst to Present at JMP Securities Hematology Summit
RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company...
Year: 2020
Prevail Therapeutics Announces First Patient Dosed in Phase 1/2 PROCLAIM Clinical Trial Evaluating PR006 for the Treatment of Frontotemporal Dementia Patients with GRN Mutations
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based...
Altimmune to Present at the 4th Annual NASH Summit 2020 Digital Conference
GAITHERSBURG, Md., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....
Active Biotech Receive Milestone Payment From Neotx
PRESS RELEASE, Lund Sweden, December 11, 2020 - Active Biotech (NASDAQ STOCKHOLM: ACTI)Active Biotech AB (publ) today announce a...
Holding(s) in Company
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and...
Bone Therapeutics announces pricing of private placement
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES,...
Adding green energy to the grid: Philips, HEINEKEN, Nouryon and Signify form first Pan-European consortium for future wind farm
First Pan-European consortium for future wind farm December 11, 2020 Consortium supports the development of additional 126 Megawatt capacity at...
Polyphor Receives an Additional USD 2.3 Million Award From CARB-X to Support Ongoing Development of a New Class of Antibiotics Targeting Multi-Drug Resistant Gram-Negative Pathogens
ALLSCHWIL, Switzerland, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Polyphor AG (SIX: POLN) today announced the extension of its existing grant...
Director/PDMR Shareholding
DXS INTERNATIONAL PLC Notification of Director / PDMR Dealing The Board of DXS International plc (the “Company”), the AQSE Growth...
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the...
Nicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment
Press ReleaseNicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment December 11, 2020 – release at 7:30...
Innate Pharma to return US and EU Lumoxiti commercialization rights to AstraZeneca
Marseille, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Innate will no longer pursue Lumoxiti commercialization activities in US or EU; Company...
Innate Pharma to Return US and EU Lumoxiti Commercialization Rights to AstraZeneca
Innate will no longer pursue Lumoxiti commercialization activities in US or EU; Company to re-focus investments in its R&D portfolio Companies...
Nabriva Therapeutics Announces Pricing of $15 Million Public Offering
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical...
4D Molecular Therapeutics Announces Upsized Pricing of Initial Public Offering
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (4DMT), a clinical-stage gene therapy company harnessing the...
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys® SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2...
Vivos Therapeutics Announces Pricing of $21M Initial Public Offering
HIGHLANDS RANCH, Colo., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel...
Egan-Jones Recommends Against Electing Dissident’s Full Slate of Nominees to Ziopharm Board
Recommends Against Electing WaterMill Nominee Jaime Vieser Ziopharm Continues to Recommend that Shareholders Support Company’s Strong Progress by Returning the...
Option Care Health Announces Pricing of Secondary Offering of 10,000,000 Shares of Common Stock
BANNOCKBURN, Ill., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH)...
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
FDA expected to make a decision on Emergency Use Authorization in the coming daysPositive vote based on totality of scientific...